Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Qualcomm
QCOM
5
American Express
AXP
No Data
Leerink Partners Maintains Intellia Therapeutics(NTLA.US) With Buy Rating, Announces Target Price $27
Express News | Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Intellia Therapeutics, Inc. (NTLA): A Bear Case Theory
Intellia Therapeutics (NTLA): Valuation Insights After NTLA-2001 Safety Setback and Analyst Downgrade
The Short List — Top 10 Most Shorted Stocks Right Now
Intellia Therapeutics (NTLA) Downgraded After Safety Concerns and Regulatory Delays Slow Gene-Editing Progress